MAB21L1 (mab-21 like 1)
|
Gene
Gene information from NCBI Gene database.
|
|
| Entrez ID | 4081 |
| Gene name | Mab-21 like 1 |
| Gene symbol | MAB21L1 |
| Synonyms (NCBI Gene) |
CAGR1COFGNbla00126
|
| Chromosome | 13 |
| Chromosome location | 13q13.3 |
| Summary | This gene is similar to the MAB-21 cell fate-determining gene found in C. elegans. It may be involved in eye and cerebellum development, and it has been proposed that expansion of a trinucleotide repeat region in the 5` UTR may play a role in a variety of |
|
miRNA
miRNA information provided by mirtarbase database.
118
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
Gene ontology (GO)
Gene Ontology (GO) annotations describing the biological processes, molecular functions, and cellular components associated with a gene.
14
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
Other IDs
Other IDs provides unique identifiers for this gene in OMIM, HGNC, and Ensembl databases.
|
|||||||
|
|||||||
|
Protein
Protein information from UniProt database.
|
|||||||||||
|
UniProt ID
Unique identifier for the protein in the UniProt database. Click to view detailed protein information.
|
Q13394 | ||||||||||
| Protein name | Putative nucleotidyltransferase MAB21L1 (EC 2.7.7.-) (Protein mab-21-like 1) | ||||||||||
| Protein function | Putative nucleotidyltransferase required for several aspects of embryonic development including normal development of the eye (PubMed:27103078, PubMed:30487245). It is unclear whether it displays nucleotidyltransferase activity in vivo (PubMed:2 | ||||||||||
| PDB | 5EOG , 5EOM | ||||||||||
| Family and domains |
Pfam
|
||||||||||
| Tissue specificity | TISSUE SPECIFICITY: Expressed in brain, cerebellum and skeletal muscle. {ECO:0000269|PubMed:8733127}. | ||||||||||
| Sequence |
|
||||||||||
| Sequence length | 359 | ||||||||||
| Interactions | View interactions | ||||||||||
|
Associated diseases
Disease associations from ClinVar categorized as Causal (Pathogenic/Likely Pathogenic) or Unknown.
7
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||